...
首页> 外文期刊>Clinical and Experimental Nephrology >Successful therapy with tonsillectomy for severe ISKDC grade VI Henoch–Schönlein purpura nephritis and persistent nephrotic syndrome
【24h】

Successful therapy with tonsillectomy for severe ISKDC grade VI Henoch–Schönlein purpura nephritis and persistent nephrotic syndrome

机译:扁桃体切除术成功治疗严重ISKDC六级Henoch-Schönlein紫癜性肾炎和持续性肾病综合征

获取原文
           

摘要

Henoch–Schönlein purpura (HSP) is a systemic disorder characterized by leukocytoclastic vasculitis involving the capillaries and the deposition of IgA immune complexes. Renal involvement is the principal cause of morbidity and mortality in children with HSP. We report here a 13-year-old girl with Henoch–Schönlein purpura nephritis (HSPN) of International Study of Kidney Disease in Children (ISKDC) grade VI and persistent nephrotic syndrome despite receiving conventional therapy, such as prednisolone, methylprednisolone and urokinase pulse therapy and plasmapheresis (PP). The patient was treated with tonsillectomy, which subsequently decreased proteinuria, induced the disappearance of microscopic hematuria, and improved renal pathological findings. A regimen of methylprednisolone and urokinase pulse therapy plus PP with tonsillectomy may be an effective and useful therapy for some children with severe HSPN children of ISKDC grade VI and persistent nephrotic syndrome.
机译:过敏性紫癜(HSP)是一种系统性疾病,其特征是白细胞碎裂性血管炎涉及毛细血管和IgA免疫复合物的沉积。肾脏受累是HSP患儿发病和死亡的主要原因。我们在这里报告了尽管接受常规治疗(如泼尼松龙,甲基强的松龙和尿激酶脉冲疗法)的儿童肾脏病国际研究(ISKDC)六级和持续性肾病综合征的一名13岁的患有过敏性紫癜性紫癜性肾炎(HSPN)的女孩和血浆置换术(PP)。该患者接受扁桃体切除术治疗,随后扁桃体蛋白尿减少,显微镜下血尿消失并改善了肾脏的病理表现。甲基强的松龙和尿激酶脉冲疗法加PP扁桃体切除术的方案可能对某些ISKDC严重VI级HSPN儿童和持续性肾病综合征的儿童有效而有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号